The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation

Por um escritor misterioso
Last updated 14 julho 2024
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
IJMS, Free Full-Text
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Dox induces caspase-1–independent processing and release of IL-1 b
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Modulation of the NLRP3 inflammasome by the ubiquitin system. The
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Neddylation Regulation of Immune Responses
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Control of the inflammasome by the ubiquitin system - Lopez
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Control of the inflammasome by the ubiquitin system - Lopez
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
IJMS, Free Full-Text
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Delicate regulation of IL-1β-mediated inflammation by cyclophilin
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it  for proteasomal degradation
Convallatoxin inhibits IL‐1β production by suppressing zinc finger

© 2014-2024 hellastax.gr. All rights reserved.